Mark Sterckel

Mark Sterckel is a Managing Director at Sterckel Innovation, based in Küssnacht am Rigi, Switzerland. He is recognized as a passionate expert in patient engagement and innovation within the healthcare sector. His professional journey includes significant roles in various pharmaceutical companies, where he has developed and executed global patient engagement strategies, particularly in neurology and personalized healthcare.

Professional Background

• Current Role: Managing Director at Sterckel Innovation, focusing on fostering innovation and enhancing patient experiences in clinical settings.

• Previous Positions:

  • Senior Director of Global Patient Advocacy at Alexion Pharmaceuticals, where he led advocacy strategies for neurology and rare diseases.
  • Sr. Patient Engagement Director at Ferring Pharmaceuticals, implementing patient engagement strategies across global products.
  • Patient Partnership Principal Director at Roche, responsible for patient engagement strategies in personalized healthcare.

Skills and Expertise

Mark Sterckel is adept at integrating innovative technologies with patient advocacy, enhancing disease awareness, and developing patient support programs. He emphasizes collaboration across diverse stakeholders, including patient advocacy groups and biopharma partners. His leadership style is characterized by a results-driven approach, focusing on cross-functional value and mentoring emerging leaders in the industry.

Sterckel's career reflects a commitment to improving patient experiences through innovation and effective communication, making him a notable figure in the healthcare innovation landscape.1